A risk-benefit assessment of intra-articular corticosteroids in rheumatic disorders

Drug Safety

Volumn 21, Issue 5, 1999, Pages 353-365

  Hunter, John A ^a   Blyth, Thomas H ^a  

^a GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; CHLOROETHANE; COLCHICINE; CORTICOSTEROID; HEPARIN; HYDROCORTISONE; LIDOCAINE; METHYLPREDNISOLONE; OSMIUM TETRAOXIDE; PYROPHOSPHATE; RADIOISOTOPE; RIFAMPICIN; RIMEXOLONE; TRIAMCINOLONE; WARFARIN;

ARTHRALGIA; ASEPSIS; ATROPHY; BACTERIAL ARTHRITIS; BONE NECROSIS; CLINICAL TRIAL; COLLOID; CORTICOSTEROID THERAPY; CUSHINGOID SYNDROME; DIABETES MELLITUS; DISEASE CONTROL; FLUID RETENTION; HOT FLUSH; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INFLAMMATORY DISEASE; INTRAARTICULAR DRUG ADMINISTRATION; JOINT STIFFNESS; JUVENILE RHEUMATOID ARTHRITIS; LACTATION; LOW BACK PAIN; NONHUMAN; ORAL DRUG ADMINISTRATION; OSTEOARTHRITIS; OSTEOPOROSIS; PAIN; PANCREATITIS; PREGNANCY; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; RHEUMATIC DISEASE; RHEUMATIC POLYMYALGIA; RISK BENEFIT ANALYSIS; SUBCUTANEOUS DRUG ADMINISTRATION; TOPICAL DRUG ADMINISTRATION; UTERUS BLEEDING; VERTIGO;

ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS; HUMANS; INJECTIONS, INTRA-ARTICULAR; RHEUMATIC DISEASES; RISK FACTORS;

EID: 0032752876     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-199921050-00002     Document Type: Review

References (85)

1. 1. Hench P, Kendall EC, Slocumb CH, et al. The effects of a hormone of the adrenal cortex and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Mayo Clin Proc 1949; 24: 181-97
2. 2. Hollander JL, Brown Jr EM, Jessar RA, et al. Hydrocortisone and cortisone injected into arthritic joints: comparative effects of and use of hydrocortisone as a local antiarthritic agent. JAMA 1951; 147: 1629-35
3. 3. Derendorf H, Mollmann H, Gruner A, et al. Pharmacokinetics and pharmacodynamics of glucocorticoid suspensions after intraarticular administration. Clin Pharmacol Ther 1986; 39: 313-7
4. 4. Ward MM, Fries JF. Trends in antirheumatic medication use among patients with rheumatoid arthritis, 1981-1996. J Rheumatol 1998; 25, 408-16
5. 5. Blyth T, Hunter JA, Stirling A. Pain refief in the rheumatoid knee after steroid injection: a single-blind comparison of hydrocortisone succinate, and triamcinolone acetonide or hexacetonide. Br J Rheumatol 1994; 33: 461-3
6. 6. Firestein GS, Paine MM, Littman BH. Gene expression (collagenase, tissue inhibitor of metalloproteinases, complement and HLA-DR) in rheumatoid arthritis and osteoarthritis synovium: quantitative analysis and effect of intraarticular corticosteroids. Arthritis Rheum 1991; 34: 1094-105
7. 7. Pelletier J-P, Martel-Pelletier J. Cartilage degradation by neutral proteoglycanases in experimental osteoarthritis: suppression by steroids. Arthritis Rheum 1985; 28: 1393-401
8. 8. Hollander JL. Intrasynovial corticosteroid therapy in arthritis. Md Med J 1970; 19: 62-6
9. 9. Hollander JL, Jessar RA, Restifo RA, et al. A new intra-articular steroid ester with longer effectiveness [abstract]. Arthritis Rheum 1961; 4: 422
10. 10. Kendall PH. Triamcinolone hexacetonide: a new corticosteroid for intra-articular therapy. Ann Phys Med 1967; 9: 55-8
11. 11. Derendorf H, Mollman HW, Barth J. Comparative pharmacokinetic evaluation of glucocorticoids after intra-articular administration [in German]. Aktuel Rheumatol 1990; 15: 145-53
12. 12. Balfour JA, Benfield P. Rimcxolone. Biodrugs 1997; 7: 158-63
13. 13. McCarty DJ, Faires JS. A comparison of the duration of local anti-inflammatory effect of several adrenocorticosteroid esters - a bioassay technique. Curr Therapy Res 1963; 5: 284-90
14. 14. McCarty DJ, Harman JG, Grassanovich JL, et al. Treatment of rheumatoid joint inflammation with intrasynovial triamcinolone hexacetonide. J Rheumatol 1995; 22: 1631-5
15. 15. Chakravarty K, Pharaoh PDP, Scott DGI. A randomised controlled study of post injection rest following intra-articular steroid therapy for knee synovitis. Br J Rheumatol 1994; 33: 464-8
16. 16. Neustadt DH. Treatment of rheumatoid joint inflammation with intrasynovial triamcinolone. J Rheumatol 1997; 24: 1349-50
17. 17. Chatham W, Williams G, Moreland L, et al. Intraarticular corticosteroid injections: should we rest the joints? Arthritis Care Res 1989; 2:70-4
18. 18. Sykes HR, Eyes B, Williams E, et al. The accuracy of blind intra-articular injections [abstract]. Br J Rheumatol 1994; 33 Suppl 1: 132
19. 19. Jones A, Regan M, Ledingham J, et al. Importance of placement of intra-articular steroid injections. BMJ 1993; 307: 1393-40
20. 20. Eustace JA, Brophy DP, Gibney RP, et al. Comparison of the accuracy of steroid placement with clinical outcome in patients with shoulder symptoms. Ann Rheum Dis 1997; 56: 59-63
21. 21. Caldwell JR. Intra-articular corticosteroids: guide to selection and indications for use. Drugs 1996; 52: 507-14
22. 22. Blyth T, Stirling A, Coote J, et al. Injection of the rheumatoid knee: does intra-articular methotrexate or rifampicin add to the benefits of triamcinolone hexacetonide? Br J Rheumatol 1998; 37: 770-2
23. 23. Gordon MM, Blyth T, Hunter JA. A comparison of glenohumeral injections of triamcinolone acetonide (TA) and triamcinolone hexacetonide (TH) in the painful rheumatoid shoulder [abstract]. Br J Rheumatol 1995; 35 Suppl. 1: 78
24. 24. Blyth TH, Irvine S, Paterson AS, et al. A comparison of orthoses [ankle foot orthosis (AFO) or Malleoloc] and steroid injections in the painful rheumatoid ankle. Scand J Rheumatol. 1998; Suppl. 108
25. 25. Belch JJF, McMillan NC, Fogelman I, et al. Combined phlebography and arthrography in patients with painful swollen calf. BMJ 1981; 282: 949
26. 26. Kelly IGK. The source of shoulder pain in rheumatoid arthritis: its implications for surgery. J Shoulder Elbow Surg 1994; 3: 62-5
27. 27. Blyth TH, Hunter JA. Treatment of the rheumatoid shoulder with intra-articular steroid; a comparison of superior and anterior routes of injection [abstract]. Br J Rheumatol 1993; 32 Suppl. 1: 69
28. 28. Dixon ASt J, Graber J. Local injection therapy in rheumatic diseases. Basle: EULAR Publishers, 1989
29. 29. Helliwell P, Woodburn J. Juvenile chronic arthritis: diagnosis and management of tibio-talar and sub-talar disease [letter]. Br J Rheumatol 1998; 37: 579
30. 30. Mahler F, Fritschy D. Partial and complete ruptures of the Achilles tendon and local corticosteroid injections. Br J Sports Med 1992; 26: 7-14
31. 31. Owen DS. Aspiration and injection of joints and soft tissues. In: Kelley WN, Harris ED, Ruddy S, et al., editors. Textbook of rheumatology. 5th ed. Philadelphia: Saunders, 1997: 591-608
32. 32. Plant MJ, Borg AA, Dziedzic K, et al. Radiographic patterns and response to steroid hip injection. Ann Rheum Dis 1997; 56: 476-80
33. 33. Creamer P. Intra-articular corticosteroid injections in osteoarthritis: do they work and if so, how? Ann Rheum Dis 1997; 56: 634-6
34. 34. Dieppe PA. Are intra-articular steroid injections useful for the treatment of the osteoarthitic joint [editorial]? Br J Rheumatol 1991; 30: 199
35. 35. Hochberg MC, Altman RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis: part II: osteoarthritis of the knee: American College of Rheumatology. Arthritis Rheum 1995; 38: 1541-6
36. 36. Balch HW, Gibson JMC, El-Ghobarey AF, et al. Repeated corticosteroid injections into knee joints. Rheumatol Rehab 1977; 11: 137-40
37. 37. Gaffney K, Ledingham J, Perry JD. Intra-articular triamcinolone hexacetonide in knee osteoarthritis: factors influencing the clinical response. Ann Rheum Dis 1995; 54: 379-81
38. 38. Jones A, Doherty M. Intra-articular corticosteroids are effective in osteoarthritis but there are no clinical predictors of response. Ann Rheum Dis 1996; 11: 829-32
39. 39. Friedman DM, Moore ME. The efficacy of intra-articular steroids in osteoarthritis: a double blind study. J Rheumatol 1980; 7: 850-6
40. 40. Dieppe P, Sathapatayavongs B, Jones H, et al. Intra-articular steroids in osteoarthritis. Rheum Rehab 1980; 19: 212-7
41. 41. Gray RG, Tenenbaum J, Gottlieb NL. Local corticosteroid treatment in rheumatic disorders. Semin Arthritis Rheum 1981; 10: 231-54
42. 42. Maugars Y, Mathis C, Berthelot J-M, et al. Assessment of the efficacy of sacroiliac corticosteroid injections in spondylo-arthropathies: a double blind study. Br J Rheumatol 1996; 35: 767-70
43. 43. Carette S, Marcoux S, Truchon R, et al. A controlled trial of corticosteroid injections into facet joints for chronic low back pain. N Engl J Med 1991; 325: 1002-7
44. 44. Huppertz H-I, Tschammler A, Horwitz A, et al. Intra-articular corticosteroids for chronic arthritis in children: efficacy and effects on cartilage and growth. J Paediatr 1995; 127; 317-21
45. 45. Green S, Buchbinder R, Glazier R, et al. Systematic review of randomised controlled trials of interventions for painful shoulder: selection criteria, outcome assessment, and efficacy. BMJ 1998; 316: 354-60
46. 46. Szebenyi B, Dieppe P. Interventions to treat shoulder pain [letter]. BMJ 1998; 316: 1676
47. 47. Patrick M, Doherty M. Facial flushing after intra-articular injection of steroid. BMJ 1987; 295: 1380
48. 48. Kahn CB, Hollander JL, Schumacher HR. Corticosteroid crystals in synovial fluid. JAMA 1970; 211: 807-9
49. 49. McCarty DJ, Hogan JM. Inflammatory reaction after intrasynovial injection of microcrystalline adrenocorticosteroid esters. Arthritis Rheum 1964; 7: 359-67
50. 50. Berger RG, Yount WJ. Immediate 'steroid flare' from intra-articular triamcinolone hexacetonide injection: case report and review of the literature. Arthritis Rheum 1990; 33: 1284-6
51. 51. Ostensson A, Geborek P. Septic arthritis as a non-surgical complication in rheumatoid arthritis: relation to disease severity and therapy. Br J Rheumatol 1991; 30: 35-8
52. 52. Cawley PJ, Morris IM. A study to compare the efficacy of two methods of skin preparation prior to joint injection. Br J Rheumatol 1992; 31: 847-8
53. 53. Alarcon-Segovia D, Ward LE. Charcot-like arthropathy in rheumatoid arthritis: consequence of overuse of a joint repeatedly injected with hydrocortisone. JAMA 1965; 193: 136-8
54. 54 Bentley G, Goodfellow JW. Disorganization of the knees following intra-articular hydrocortisone injections. J Bone Joint Surg 1969; 51B: 498-502
55. 55. Chandler GN, Wright V. Deleterious effect of intra-articular hydrocortisone. Lancet 1985; 11: 661-3
56. 56. Laroche M, Arlet J, Mazieres B. Osteonecrosis of the femoral and humeral heads after intra-articular corticosteroid injections. J Rheumatol 1990; 17: 549-51
57. 57. Roberts WN, Babcock EA, Breitbach SA, et al. Corticosteroid injection in rheumatoid arthritis does not increase rate of total joint arthroplasty. J Rheumatol 1996; 23: 1001-4
58. 58. Butler M, Colombo C, Hickman L, et al. A new model of osteoarthritis in rabbits: III; evaluation of anti-osteoarthritic effects of selected drugs administered intraarticularly. Arthritis Rheum 1983; 26: 380-6
59. 59. Williams JM, Brandt KD. Triamcinolone hexacetonide protects against fibrillation and osteophyte formation following chemically induced articular cartilage damage. Arthritis Rheum 1985; 28: 1267-74
60. 60. Pelletier J-P, DiBattista JA, Raynauld JP, et al. The in vivo effects of intraarticular corticosteroid injections on cartilage lesions, stromelysin, interleukin-1, and oncogene protein synthesis in experimental osteoarthritis. J Clin Lab Invest 1995; 72: 578-86
61. 61. Pelletier J-P, Martel-Pelletier J, Cloutier JM, et al. Proteoglycan-degrading acid metalloprotease activity in human osteoarthritic cartilage, and the effect of intraarticular steroid injections. Arthritis Rheum 1987; 30: 541-8
62. 62. Mankin HF, Conger KA. The acute effects of IA hydrocortisone on articular cartilage in rabbits. J Bone Joint Surg 1966; 48: 1383-8
63. 63. Gottlieb NL, Penneys NS, Brown Jr HE. Periarticular perilymphatic skin atrophy after intra-articular corticosteroid injections. JAMA 1978; 240: 559-60
64. 64. Cunningham GR, Goldzieher JW, de la Pena A, et al. The mechanism of ovulation inhibition by triamcinolone acctonide. J Clin Endocrinol Metab 1978; 46: 8-14
65. 65. Emkey RD, Lindsay R, Lyssy J, et al. The systemic effect of intra-articular administration of corticosteroid on markers of bone formation and bone resorption in patients with rheumatoid arthritis. Arthritis Rheum 1996; 37: 277-82
66. 66. Gerster JC, Fallet GH. Periarticular hydroxyapatite deposition after corticosteroid injections. J Rheumatol 1987; 14: 1156-9
67. 67. Schuster S, Williams IA. Adrenal suppression due to intra-articular steroid therapy. Lancet 1961; 11: 171
68. 68. Reid DM, Eastmond C, Rennie JAN. Hypothalamic-pituitary-adrenal suppression after repeated intra-articular injection. Ann Rheum Dis 1986; 45; 87
69. 69. Esselinckx W, Kotanowski J, Ngant de Deuxchaisnes CH. Adrenocortical function and responsiveness to tetracosactrin infusions after intra-articular treatment with triamcinolone acetonide and hydrocortisone acetate. Clin Rheumatol 1982; 1: 176-84
70. 70. Lazarevic MB, Shosey JL, Djordjevic-Denic G, et al. Reduction of cortisol levels after single intra-articular and intramuscular injections. Am J Med 1995; 99: 370-3
71. 71. Committee on Safety of Medicines/Medicines Control Agency. Systemic corticosteroids in pregnancy and lactation. Curr Probl Pharmacovig 1998; 24: 9
72. 72. Thumboo J, O'Duffy JD. A prospective study of the safety of joint and soft tissue aspirations and injections in patients taking warfarin sodium. Arthritis Rheum 1998; 41: 736-9
73. 73. Pal B, Nash EJ, Oppenheim B, et al. Routine synovial fluid culture: is it necessary? Lessons from an audit. Br J Rheumatol 1997; 36: 1116-7
74. 74. Sharma A, Baethge BA, Acebes JC, et al. Arthroscopic lavage treatment in rheumatoid arthritis of the knee. J Rheumatol 1996; 23: 1872-4
75. 75. Gumpel JM, Roles NC. A controlled trial of intra-articular radiocolloids versus surgical synovectomy in persistent synovitis. Lancet 1975; 1: 488-9
76. 76. Gumpel JM, Matthews SA, Fisher M. Synoviorthesis with erbium-169: a double-blind controlled comparison of erbium-169 with corticosteroid. Ann Rheum Dis 1979; 38: 341-3
77. 77. Anttinen J, Oka M. Intra-articular triamcinolone hexacetonide and osmic acid in persistent synovitis of the knee. Scand J Rheumatol 1975; 4: 125-8
78. 78. Bird HA, Ring EFJ, Daniel R, et al. Comparison of intra-articular methotrexate with intra-articular triamcinofone hexacetonide. Curr Med Res Opin 1977; 5: 141-6
79. 79. Hall GH, Jones BJM, Head AC. Intra-articular methotrexate. Clinical and laboratory study in rheumatoid and psoriatic arthritis. Ann Rheum Dis 1978; 37: 351-6
80. 80. Wobig M, Dickhul A, Maier R, et al. Viscosupplementation with hylan G-F 20: a 20 week controlled trial of efficacy and safety in the osteoarthritic knee. Clin Ther 1998; 20: 410-23
81. 81. Goebel KM, Storck U, Neurath F. Intra-synovial orgotein therapy in rheumatoid arthritis. Lancet 1981; 1: 1015-17
82. 82. Gammer W, Broback LG. Clinical comparison of orgotein and methylprednisolone acetate in the treatment of osteoarthritis of the knee joint. Scand J Rheumatol 1984; 13: 108-12
83. 83. Goebel KM, Storck U. Effect of intra-articular orgotein versus corticosteroid on rheumatoid arthritis of the knees. Am J Med 1983; 74; 124-8
84. 84. Kirwan JR, Arthritis and Rheumatism Council Low Dose Glucocorticoid Study Group. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. N Engl J Med 1995; 333: 142-6
85. 85. Haslock I, MacFarlane D, Speed C. Intra-articular and soft tissue injections: a survey of current practice. Br J Rheumatol 1995; 34: 449-52